•
PA
PALI
Palisade Bio, Inc. Common Stock
polygonBIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
--
Price Chart
Market Cap
281.99M
Volume
5.96M
52W High
$2.64
52W Low
$0.53
Open
$1.89
Prev Close
$1.89
Day Range
1.71 - 1.90
About Palisade Bio, Inc. Common Stock
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
Latest News
Palisade Bio Announces Cancellation of Special Meeting of Stockholders
GlobeNewswire Inc.•Oct 9
Palisade Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire Inc.•Jan 3
Palisade Bio to Participate in the Virtual Investor Closing Bell Series
GlobeNewswire Inc.•Jun 24
Palisade Bio Provides Update on Advancement of its Strategic Collaboration with Strand Life Sciences
GlobeNewswire Inc.•Jun 21
Bears are Losing Control Over Palisade Bio (PALI), Here's Why It's a 'Buy' Now
Zacks Investment Research•Jun 14
Palisade Bio Announces Notice of Allowance for Canadian Patent Covering Lead Product Candidate, PALI-2108
GlobeNewswire Inc.•Jun 11
Palisade Bio to Present at the Virtual Investor Pitch Conference
GlobeNewswire Inc.•Jun 10
Palisade Bio Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire Inc.•May 14